Matches in Wikidata for { <http://www.wikidata.org/entity/Q79633839> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q79633839 description "article scientifique publié en 2007" @default.
- Q79633839 description "artículu científicu espublizáu en xineru de 2007" @default.
- Q79633839 description "im Januar 2007 veröffentlicher wissenschaftlicher Artikel" @default.
- Q79633839 description "scientific article published on 23 January 2007" @default.
- Q79633839 description "wetenschappelijk artikel" @default.
- Q79633839 description "наукова стаття, опублікована в січні 2007" @default.
- Q79633839 name "Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments?" @default.
- Q79633839 name "Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments?" @default.
- Q79633839 type Item @default.
- Q79633839 label "Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments?" @default.
- Q79633839 label "Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments?" @default.
- Q79633839 prefLabel "Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments?" @default.
- Q79633839 prefLabel "Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments?" @default.
- Q79633839 P1433 Q79633839-C01EA9FA-D53D-4DF4-BBAF-C700FEC84306 @default.
- Q79633839 P1476 Q79633839-CF69D1B5-0978-4937-904D-038C5743A61D @default.
- Q79633839 P2093 Q79633839-BEFF0B6B-F179-4F44-BA2B-816C39622C0F @default.
- Q79633839 P2860 Q79633839-BEA301B5-167F-4A11-BFB8-102561923683 @default.
- Q79633839 P2860 Q79633839-F8ACDE4C-D796-4D16-929C-214C740E486C @default.
- Q79633839 P2860 Q79633839-F91964E2-1634-4BE9-A311-B363CDE6E66D @default.
- Q79633839 P304 Q79633839-B298ADD4-5A63-45FB-B644-AB028F366C95 @default.
- Q79633839 P31 Q79633839-DA058D00-F4D7-43EE-8C38-F64ECF6D2CF3 @default.
- Q79633839 P356 Q79633839-FD17D9DD-94B5-456C-BFB4-74460EA7F823 @default.
- Q79633839 P433 Q79633839-FEE4AF1E-6D64-4AF6-8C6B-A30A3AB3E255 @default.
- Q79633839 P478 Q79633839-AA219A31-F073-4A65-BD82-40566BFBF7BC @default.
- Q79633839 P577 Q79633839-52CD1339-FDB2-4278-A9C4-C9B752818606 @default.
- Q79633839 P698 Q79633839-ABFC5C90-E2C5-411A-BAA3-9728105B2B15 @default.
- Q79633839 P921 Q79633839-8C28604B-8515-4CB6-9FF2-E49C64A05D47 @default.
- Q79633839 P356 NCPONC0716 @default.
- Q79633839 P698 17245346 @default.
- Q79633839 P1433 Q15752073 @default.
- Q79633839 P1476 "Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments?" @default.
- Q79633839 P2093 "Chris H Takimoto" @default.
- Q79633839 P2860 Q34381754 @default.
- Q79633839 P2860 Q34477526 @default.
- Q79633839 P2860 Q44677767 @default.
- Q79633839 P304 "152-153" @default.
- Q79633839 P31 Q13442814 @default.
- Q79633839 P356 "10.1038/NCPONC0716" @default.
- Q79633839 P433 "3" @default.
- Q79633839 P478 "4" @default.
- Q79633839 P577 "2007-01-23T00:00:00Z" @default.
- Q79633839 P698 "17245346" @default.
- Q79633839 P921 Q412178 @default.